Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil

Abstract

BackgroundMetabolic syndrome (MetS) is an aggregation of risk factors associated with increased incidence of cardiovascular disease, type 2 diabetes mellitus, and all-cause mortality. Information on MetS prevalence is scarce in the northeast region, Brazil. This study aims to estimate the prevalence of MetS according to different diagnostic criteria in a community sample of men during the November Blue Campaign living in the metropolitan area of Natal, Rio Grande do Norte, Brazil.MethodsThis is a cross-sectional study on 500 men aged 40 years or older invited by the Blue November Campaign of 2015, an awareness program aimed at the prevention of male diseases. The evaluation included blood pressure, anthropometric measurements (weight, height, and waist circumference), fasting blood glucose, and blood lipid profile. The diagnosis of MetS was made according to the criteria of International Diabetes Federation (IDF)/American Heart Association (AHA)/National Heart, Lung, and Blood Institute (NHLBI), IDF, and National Cholesterol Education Program’s Adult Treatment Panel III (NCEP-ATPIII).ResultsThe prevalence was high by considering the following three criteria: IDF/AHA/NHLBI (66.8%), IDF (60.0%), and NCEP-ATPIII (46.4%). Concordance between diagnostic criteria measured by the kappa statistic (k) was excellent between IDF/AHA/NHLBI and IDF (k=0.85, P<0.0001) and moderate between IDF/AHA/NHLBI and NCEP-ATPIII (k=0.59) and IDF and NCEP-ATPIII (k=0.54).ConclusionPrevalence of MetS in the male population was high using the three diagnostic criteria. IDF/AHA/NHLBI and IDF criteria have a high level of agreement, but NCEP-ATPIII criteria identify a lower number of MetS cases.

High Prevalence of Metabolic Syndrome and Its Related Demographic Factors in North of Iran: Results from the PERSIAN Guilan Cohort Study

“…Metabolic syndrome (MetS) is defined as a set of risk factors such as central obesity, insulin resistance, dyslipidemia, and hypertension that increase the risk of type 2 diabetes mellitus, cardiovascular disease, cancer, and premature death [ 1 , 2 ]. It is also an important predictor of diabetes and is a simple tool for predicting subsequent CVD [ 3 – 6 ].…”

Avaliação da síndrome metabólica em agentes comunitários de saúde em município do norte de Minas Gerais

“…amplamente difundidos para a classificação da SM. 1,3,4 Introducción: El Síndrome Metabólico está relacionado con enfermedades crónicas, tiene una prevalencia creciente em Brasil y conlleva riesgos cardiovasculares para la población. Objetivo: Comparar la prevalencia de síndrome metabólico en trabajadores comunitarios de salud de un municipio del norte de Minas Gerais según los diferentes criterios diagnósticos.…”

Indicadores de aterogenicidad en la predicción del síndrome metabólico en adultos, Trujillo-Perú

“…El síndrome metabólico es un problema de salud pública que tiene una prevalencia estimada de 20% a 25% en la población general. Su prevalencia es mayor en adultos mayores, llegando al 42% en personas >60 años de edad 1 . La prevalencia en América Latina para el 2015 se estimó en 29,5% 2 .…”